Bewendin Evelyne Savadogo/Komboigo^1,2,3*, Boukaré Ouedraogo², Philibert Ouedraogo², Charlemagne Ouedraogo³, Florencia Djigma³, Jacques Simpore^3
1Higher Institute of Health Sciences, Nazi Boni University of Bobo Dioulasso, Bobo Dioulasso, Burkina Faso.
²Sourô Sanou University Hospital Center, Bobo Dioulasso, Burkina Faso.
³Laboratory of Molecular Biology and Molecular Genetics (LABIOGENE), Joseph Ki-Zerbo University of Ouagadougou, Ouagadougou, Burkina Faso.
DOI: 10.4236/ojog.2026.163050   PDF    HTML   XML   66 Downloads   359 Views   Citations

Abstract

Introduction: Molecular biology and genetics now occupy a central place in obstetrics and gynecology, offering innovative diagnostic, prognostic, and therapeutic tools. Objective: To describe the role of molecular biology and genetics in obstetrics and gynecology. Applications in Gynecology: In oncology, genetics allows us to identify new genes involved in breast, cervical, endometrial, and ovarian cancers, to identify high-risk patients, and to develop more tailored treatments to provide optimal care. Molecular biology and molecular genetics are essential for understanding infertility. They allow us to identify chromosomal, gene, and epigenetic abnormalities responsible for reproductive disorders. Applications in Obstetrics: Pregnancy is a complex physiological process involving genetic, epigenetic, hormonal, and immune interactions. Molecular abnormalities can disrupt its proper course, leading to various maternal or fetal pathologies. Prenatal diagnosis increasingly relies on molecular biology and molecular genetics. Conclusion: molecular biology and genetics allow for a better understanding of the fundamental mechanisms of reproduction, explain many causes of infertility, and shed light on the pathophysiology of the main pregnancy pathologies. These advances constitute not only powerful diagnostic and prognostic tools, but also drivers of progress toward precision obstetrics and gynecology, serving the health of women and the mother-child dyad.

Keywords

Biology, Genetics, Cancer, Infertility, Pregnancy, Burkina Faso

Share and Cite:

1. Introduction

Molecular biology involves integrating all the molecular data necessary for understanding biological mechanisms. The term “molecular biology,” commonly used in medical biology, refers to the study of nucleic acids, specifically deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA carries genetic information. Its alterations can cause congenital or acquired diseases. The advent of molecular biology has revolutionized biology, particularly genetics, and has led, among other things, to a better understanding of the pathophysiological mechanisms of genetically transmitted diseases as well as certain acquired conditions [1]-[3]. Obstetrics and gynecology, like other medical disciplines, has greatly benefited from these increasingly powerful techniques. This chapter will address molecular biology and genetics as applied to obstetrics and gynecology.

2. Basic Reminders

• Foundations of biology and molecular genetics

All cells store their hereditary information in DNA. Eukaryotic DNA is packaged into a set of chromosomes (46 chromosomes, including 44 autosomes and one pair of sex chromosomes, XX in females; XY in males). Cells replicate their hereditary information by template-based polymerization. They transcribe parts of their hereditary information into RNA. The RNA is then translated into protein by ribosomes. The gene is expressed as a protein. The gene represents the fragment of genetic information corresponding to a protein [2] [4].

• Specificity in obstetrics and gynecology

Obstetrics and gynecology is a medical discipline that deals with women at all stages of life (from puberty to menopause and beyond), including pregnancy monitoring, childbirth, postpartum care, and the prevention, diagnosis, and treatment of diseases of the female reproductive system and breasts. Obstetrics and gynecology is distinguished by its unique specialization in molecular biology and genetics. It involves two patients simultaneously: the mother and the unborn child, and sometimes the biological father, making the applications of molecular biology and genetics particularly strategic [5].

3. Applications in Gynecology

• Diagnosis and treatment of gynecological cancers

Cancer is a complex group of diseases resulting from genetic and epigenetic alterations that interfere with cell growth and death [6]. In oncology, genetics allows us to identify new genes involved in breast, cervical, endometrial and ovarian cancers, to identify high-risk patients and to develop more suitable treatments in order to offer optimal care. The involvement of various molecules in the oncogenic processes of invasion, metastasis, and treatment resistance has been demonstrated. The exponential growth of genomic and proteomic data collected over the last twenty years has led to major advances in understanding the molecular mechanisms of gynecological cancers, which have been applied to diagnostic and therapeutic strategies. Targeted therapies have been developed and adopted, particularly for advanced, refractory, or recurrent cancers, based on individual molecular profiles [6]-[10].

• Infertility and medically assisted reproduction

Infertility is a major human reproductive health problem, affecting approximately 15% of couples worldwide [11]. It is estimated that half of infertility cases have a genetic component. Molecular biology and molecular genetics are essential for understanding infertility. The advent of high-throughput sequencing technologies has greatly facilitated the identification of genetic mutations associated with infertility in patients over the past 20 years. They allow the identification of chromosomal, gene, and epigenetic abnormalities responsible for reproductive disorders, guide diagnosis, personalize care, and pave the way for innovative therapeutic approaches. In female infertility, chromosomal abnormalities (Turner syndrome) and genetic mutations responsible for early menopause have been identified through molecular biology, as well as microdeletions of the Y chromosome in azoospermia or severe oligospermia, with emerging therapeutic possibilities such as genome editing (CRISPR-Cas9) and regenerative medicine (stem cells for gametogenesis) [12]-[16].

In assisted reproductive technology (ART), preimplantation genetic diagnosis (PGD) allows for the assessment of the risks of the occurrence or recurrence of a genetic disorder. In the context of egg donation, genetic screening is a current issue that raises numerous ethical questions related to the improvement of techniques enabling the detection of an increasing number of genome mutations [17] [18].

4. Applications in Obstetrics

• Pregnancy pathologies

Pregnancy is a complex physiological process involving genetic, epigenetic, hormonal, and immune interactions. Molecular abnormalities can disrupt its proper course, leading to various maternal or fetal pathologies. These main pathologies include preeclampsia and its complications, and recurrent miscarriages related tomiRNA expression, gestational diabetes, threatened preterm labor, hydatidiform mole, Beckwith-Wiedemann syndrome (11p15 methylation alterations) and Silver-Russell syndrome (hypomethylation locus 11p15, chromosome 7 abnormalities) [19]-[30].

• Prenatal diagnosis

Antenatal diagnosis encompasses all examinations performed during pregnancy to detect chromosomal, genetic, metabolic, or morphological abnormalities in the embryo or fetus and to enable early intervention (medical, surgical, therapeutic, or even decision-making). Antenatal diagnosis increasingly relies on molecular biology and molecular genetics. These technologies offer increasingly precise and often non-invasive tools, ranging from non-invasive prenatal screening (circulating fetal DNA) to next-generation sequencing (NGS). They allow us to go beyond morphological screening to identify chromosomal (trisomy), monogenic (sickle cell disease, hemophilia), or epigenetic abnormalities, thus enabling precision fetal medicine [31] [32].

5. Conclusion

Molecular biology and genetics now occupy a central place in obstetrics and gynecology. They allow for a better understanding of the fundamental mechanisms of reproduction, explain many causes of infertility, and shed light on the pathophysiology of the main pregnancy complications. These advances constitute not only powerful diagnostic and prognostic tools, but also drivers of progress toward precision obstetrics and gynecology, serving the health of women and the mother-child dyad.

Conflicts of Interest

The authors declare no conflicts of interest regarding the publication of this paper.

References

[1]	Laudenbach, V., Mantz, J. and Desmonts, J.M. (1999) Comprendre la biologie moléculaire. Annales Françaises d’Anesthésie et de Réanimation, 18, 725-747.[CrossRef] [PubMed]
[2]	Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K. and Walter, P. (2002) Molecular Biology of the Cell. 4th Edition, Garland Science.
[3]	Khoury, M.J. and Romero, R. (2006) The Integration of Genomics into Obstetrics and Gynecology: A Huge Challenge. American Journal of Obstetrics and Gynecology, 195, 1503-1505.[CrossRef] [PubMed]
[4]	http://182.160.97.198:8080/xmlui/bitstream/handle/123456789/478/Chapter%201?sequence=2&
[5]	RPC [Internet]. CNGOF. https://cngof.fr/rpc/
[6]	Sonoda, K. (2015) Molecular Biology of Gynecological Cancer. Oncology Letters, 11, 16-22.[CrossRef] [PubMed]
[7]	Crosbie, E.J., Kitson, S.J., McAlpine, J.N., Mukhopadhyay, A., Powell, M.E. and Singh, N. (2022) Endometrial Cancer. The Lancet, 399, 1412-1428.[CrossRef] [PubMed]
[8]	Gonzalez-Angulo, A.M., Morales-Vasquez, F. and Hortobagyi, G.N. (2007) Overview of Resistance to Systemic Therapy in Patients with Breast Cancer. In: Yu, D.H. and Hung, M.-C., Eds., Breast Cancer Chemosensitivity, Springer, 1-22.[CrossRef] [PubMed]
[9]	Lang-Avérous, G., Croce, S., Mery, E. and Devouassoux-Shisheboran, M. (2021) Sentinel Lymph Node Processing in Gynecological Cancer Histopathology and Molecular Biology. Chinese Clinical Oncology, 10, 17.[CrossRef] [PubMed]
[10]	Guarneri, V. and Conte, P.F. (2004) The Curability of Breast Cancer and the Treatment of Advanced Disease. European Journal of Nuclear Medicine and Molecular Imaging, 31, S149-S161.[CrossRef] [PubMed]
[11]	Jiao, S.Y., Yang, Y.H. and Chen, S.R. (2020) Molecular Genetics of Infertility: Loss-Of-Function Mutations in Humans and Corresponding Knockout/Mutated Mice. Human Reproduction Update, 27, 154-189.[CrossRef] [PubMed]
[12]	Ferreux, L., Bourdon, M., Chargui, A., Schmitt, A., Stouvenel, L., Lorès, P., et al. (2021) Genetic Diagnosis, Sperm Phenotype and ICSI Outcome in Case of Severe Asthenozoospermia with Multiple Morphological Abnormalities of the Flagellum. Human Reproduction, 36, 2848-2860.[CrossRef] [PubMed]
[13]	Wen, X., Chai, M., Zhang, Q., Zou, H., Zhang, Z., Cao, Y., et al. (2024) Homozygous Variant of FANCM of the Fanconi Anemia Pathway Causes Premature Ovarian Insufficiency: Investigation of the Pathogenic Mechanism. Journal of Sichuan University. Medical Science Edition, 55, 559-565.
[14]	Wang, Q., Li, D., Cai, B., Chen, Q., Li, C., Wu, Y., et al. (2019) Whole-Exome Sequencing Reveals SALL4 Variants in Premature Ovarian Insufficiency: An Update on Genotype-Phenotype Correlations. Human Genetics, 138, 83-92.[CrossRef] [PubMed]
[15]	Chen, Q., Ke, H., Luo, X., Wang, L., Wu, Y., Tang, S., et al. (2020) Rare Deleterious BUB1B Variants Induce Premature Ovarian Insufficiency and Early Menopause. Human Molecular Genetics, 29, 2698-2707.[CrossRef] [PubMed]
[16]	Wambergue, C., Zouari, R., Fourati Ben Mustapha, S., Martinez, G., Devillard, F., Hennebicq, S., et al. (2016) Patients with Multiple Morphological Abnormalities of the Sperm Flagella Due to DNAH1 Mutations Have a Good Prognosis Following Intracytoplasmic Sperm Injection. Human Reproduction, 31, 1164-1172.[CrossRef] [PubMed]
[17]	Lai, Z., Wang, Y., Zhou, W., Liang, Z., Shi, J., Yang, H., et al. (2022) Single-Cell Transcriptome Profiling of the Human Endometrium of Patients with Recurrent Implantation Failure. Theranostics, 12, 6527-6547.[CrossRef] [PubMed]
[18]	Colaco, S. and Modi, D. (2018) Genetics of the Human Y Chromosome and Its Association with Male Infertility. Reproductive Biology and Endocrinology, 16, Article No. 14.[CrossRef] [PubMed]
[19]	Bennett, P.R., Brown, R.G. and MacIntyre, D.A. (2020) Vaginal Microbiome in Preterm Rupture of Membranes. Obstetrics and Gynecology Clinics of North America, 47, 503-521.[CrossRef] [PubMed]
[20]	Rout, M. and Lulu S, S. (2018) Molecular and Disease Association of Gestational Diabetes Mellitus Affected Mother and Placental Datasets Reveal a Strong Link between Insulin Growth Factor (IGF) Genes in Amino Acid Transport Pathway: A Network Biology Approach. Journal of Cellular Biochemistry, 120, 1577-1587.[CrossRef] [PubMed]
[21]	Feng, Y., Qu, X., Chen, Y., Feng, Q., Zhang, Y., Hu, J., et al. (2020) MicroRNA-33a-5p Sponges to Inhibit Pancreatic β-Cell Function in Gestational Diabetes Mellitus LncRNA DANCR. Reproductive Biology and Endocrinology, 18, Article No. 61.[CrossRef] [PubMed]
[22]	Bhushan, R., Rani, A., Gupta, D., Ali, A. and Dubey, P.K. (2022) MicroRNA-7 Regulates Insulin Signaling Pathway by Targeting IRS1, IRS2, and RAF1 Genes in Gestational Diabetes Mellitus. MicroRNA, 11, 57-72.[CrossRef] [PubMed]
[23]	Taylor, A.H., Bachkangi, P. and Konje, J.C. (2023) Labour and Premature Delivery Differentially Affect the Expression of the Endocannabinoid System in the Human Placenta. Histochemistry and Cell Biology, 160, 577-593.[CrossRef] [PubMed]
[24]	Page, J.M. and Silver, R.M. (2016) Genetic Causes of Recurrent Pregnancy Loss. Clinical Obstetrics & Gynecology, 59, 498-508.[CrossRef] [PubMed]
[25]	Ohwaki, A., Nishizawa, H., Kato, A., Kato, T., Miyazaki, J., Yoshizawa, H., et al. (2020) Placental Genetic Variants in the Upstream Region of the FLT1 Gene in Pre-eclampsia. Journal of Reproduction & Infertility, 21, 240-246.[CrossRef] [PubMed]
[26]	Tan, C.Y., Ho, J.F.V., Chong, Y.S., Loganath, A., Chan, Y.H., Ravichandran, J., et al. (2008) Paternal Contribution of HLA-G*0106 Significantly Increases Risk for Pre-Eclampsia in Multigravid Pregnancies. MHR: Basic Science of Reproductive Medicine, 14, 317-324.[CrossRef] [PubMed]
[27]	Hansen, A.T., Bernth Jensen, J.M., Hvas, A. and Christiansen, M. (2018) The Genetic Component of Preeclampsia: A Whole-Exome Sequencing Study. PLOS ONE, 13, e0197217.[CrossRef] [PubMed]
[28]	Meng, Y., Meng, Y., Li, L., Li, Y., He, J. and Shan, Y. (2024) The Role of DNA Methylation in Placental Development and Its Implications for Preeclampsia. Frontiers in Cell and Developmental Biology, 12, Article ID: 1494072.[CrossRef] [PubMed]
[29]	Brioude, F., Kalish, J.M., Mussa, A., Foster, A.C., Bliek, J., Ferrero, G.B., et al. (2018) Clinical and Molecular Diagnosis, Screening and Management of Beckwith-Wiedemann Syndrome: An International Consensus Statement. Nature Reviews Endocrinology, 14, 229-249.[CrossRef] [PubMed]
[30]	Wakeling, E.L., Brioude, F., Lokulo-Sodipe, O., O’Connell, S.M., Salem, J., Bliek, J., et al. (2016) Diagnosis and Management of Silver-Russell Syndrome: First International Consensus Statement. Nature Reviews Endocrinology, 13, 105-124.[CrossRef] [PubMed]
[31]	Lee, T., LeShane, E.S., Messerlian, G.M., Canick, J.A., Farina, A., Heber, W.W., et al. (2002) Down Syndrome and Cell-Free Fetal DNA in Archived Maternal Serum. American Journal of Obstetrics and Gynecology, 187, 1217-1221.[CrossRef] [PubMed]
[32]	Spencer, K., de Kok, J.B. and Swinkels, D.W. (2026) Increased Total Cell-Free DNA in the Serum of Pregnant Women Carrying a Fetus Affected by Trisomy 21. Prenatal Diagnosis, 23, 580-583. https://obgyn.onlinelibrary.wiley.com/doi/10.1002/pd.647[CrossRef] [PubMed]